{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:06:32Z","timestamp":1792508792061,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"crossref","award":["2018R1D1A1A02044017"],"award-info":[{"award-number":["2018R1D1A1A02044017"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"crossref","award":["2020R1A5A2017323"],"award-info":[{"award-number":["2020R1A5A2017323"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"crossref","award":["2021R1F1A1047379"],"award-info":[{"award-number":["2021R1F1A1047379"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"crossref","award":["RS-2023-00223069"],"award-info":[{"award-number":["RS-2023-00223069"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"crossref","award":["2023R1A2C2003446"],"award-info":[{"award-number":["2023R1A2C2003446"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001866","name":"National Research Fund","doi-asserted-by":"crossref","award":["RS-2023-00225239"],"award-info":[{"award-number":["RS-2023-00225239"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cerebral organoids (COs) are the most advanced in vitro models that resemble the human brain. The use of COs as a model for Alzheimer\u2019s disease (AD), as well as other brain diseases, has recently gained attention. This study aimed to develop a human AD CO model using normal human pluripotent stem cells (hPSCs) that recapitulates the pathological phenotypes of AD and to determine the usefulness of this model for drug screening.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We established AD hPSC lines from normal hPSCs by introducing genes that harbor familial AD mutations, and the COs were generated using these hPSC lines. The pathological features of AD, including extensive amyloid-\u03b2 (A\u03b2) accumulation, tauopathy, and neurodegeneration, were analyzed using enzyme-linked immunosorbent assay, Amylo-Glo staining, thioflavin-S staining, immunohistochemistry, Bielschowsky\u2019s staining, and western blot analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The AD COs exhibited extensive A\u03b2 accumulation. The levels of paired helical filament tau and neurofibrillary tangle-like silver deposits were highly increased in the AD COs. The number of cells immunoreactive for cleaved caspase-3 was significantly increased in the AD COs. In addition, treatment of AD COs with BACE1 inhibitor IV, a \u03b2-secretase inhibitor, and compound E, a \u03b3-secretase inhibitor, significantly attenuated the AD pathological features.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our model effectively recapitulates AD pathology. Hence, it is a valuable platform for understanding the mechanisms underlying AD pathogenesis and can be used to test the efficacy of anti-AD drugs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-024-03732-1","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T11:02:14Z","timestamp":1713956534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Simple modeling of familial Alzheimer\u2019s disease using human pluripotent stem cell-derived cerebral organoid technology"],"prefix":"10.1186","volume":"15","author":[{"given":"Mu Seog","family":"Choe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Cheol","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Ryong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Min","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na-Yeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murim","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0067-2803","authenticated-orcid":false,"given":"Min Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"issue":"4","key":"3732_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","volume":"120","author":"RE Tanzi","year":"2005","unstructured":"Tanzi RE, Bertram L. Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120(4):545\u201355. https:\/\/doi.org\/10.1016\/j.cell.2005.02.008","journal-title":"Cell"},{"issue":"12","key":"3732_CR2","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1038\/s41380-018-0229-8","volume":"23","author":"C Gonzalez","year":"2018","unstructured":"Gonzalez C, Armijo E, Bravo-Alegria J, Becerra-Calixto A, Mays CE, Soto C. Modeling amyloid beta and tau pathology in human cerebral organoids. Mol Psychiatry. 2018;23(12):2363\u201374. https:\/\/doi.org\/10.1038\/s41380-018-0229-8","journal-title":"Mol Psychiatry"},{"issue":"4","key":"3732_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s41380-018-0343-7","volume":"24","author":"Y Gerakis","year":"2019","unstructured":"Gerakis Y, Hetz C. Brain organoids: a next step for humanized Alzheimer\u2019s disease models? Mol Psychiatry. 2019;24(4):474\u20138. https:\/\/doi.org\/10.1038\/s41380-018-0343-7","journal-title":"Mol Psychiatry"},{"issue":"9","key":"3732_CR4","doi-asserted-by":"publisher","first-page":"e0163072","DOI":"10.1371\/journal.pone.0163072","volume":"11","author":"HK Lee","year":"2016","unstructured":"Lee HK, Velazquez Sanchez C, Chen M, Morin PJ, Wells JM, Hanlon EB, et al. Three Dimensional Human Neuro-Spheroid Model of Alzheimer\u2019s Disease Based on Differentiated Induced Pluripotent Stem cells. PLoS ONE. 2016;11(9):e0163072. https:\/\/doi.org\/10.1371\/journal.pone.0163072","journal-title":"PLoS ONE"},{"issue":"1","key":"3732_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jcp.24683","volume":"230","author":"M Ravi","year":"2015","unstructured":"Ravi M, Paramesh V, Kaviya SR, Anuradha E, Solomon FD. 3D cell culture systems: advantages and applications. J Cell Physiol. 2015;230(1):16\u201326. https:\/\/doi.org\/10.1002\/jcp.24683","journal-title":"J Cell Physiol"},{"issue":"1","key":"3732_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40035-021-00252-3","volume":"10","author":"FC Bi","year":"2021","unstructured":"Bi FC, Yang XH, Cheng XY, Deng WB, Guo XL, Yang H, et al. Optimization of cerebral organoids: a more qualified model for Alzheimer\u2019s disease research. Transl Neurodegener. 2021;10(1):27. https:\/\/doi.org\/10.1186\/s40035-021-00252-3","journal-title":"Transl Neurodegener"},{"issue":"7526","key":"3732_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi SH, Kim YH, Hebisch M, Sliwinski C, Lee S, D\u2019Avanzo C, et al. A three-dimensional human neural cell culture model of Alzheimer\u2019s disease. Nature. 2014;515(7526):274\u20138. https:\/\/doi.org\/10.1038\/nature13800","journal-title":"Nature"},{"key":"3732_CR8","doi-asserted-by":"publisher","unstructured":"Amin ND, Pasca SP. Building Models of Brain Disorders with Three-Dimensional Organoids. Neuron. 2018;100(2):389\u2013405. https:\/\/doi.org\/10.1016\/j.neuron.2018.10.007","DOI":"10.1016\/j.neuron.2018.10.007"},{"issue":"7","key":"3732_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nmeth.4304","volume":"14","author":"JA Bagley","year":"2017","unstructured":"Bagley JA, Reumann D, Bian S, Levi-Strauss J, Knoblich JA. Fused cerebral organoids model interactions between brain regions. Nat Methods. 2017;14(7):743\u201351. https:\/\/doi.org\/10.1038\/nmeth.4304","journal-title":"Nat Methods"},{"issue":"12","key":"3732_CR10","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1016\/j.celrep.2016.12.001","volume":"17","author":"C Luo","year":"2016","unstructured":"Luo C, Lancaster MA, Castanon R, Nery JR, Knoblich JA, Ecker JR. Cerebral organoids recapitulate epigenomic signatures of the human fetal brain. Cell Rep. 2016;17(12):3369\u201384. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.001","journal-title":"Cell Rep"},{"issue":"7715","key":"3732_CR11","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/d41586-018-05722-9","volume":"559","author":"A King","year":"2018","unstructured":"King A. The search for better animal models of Alzheimer\u2019s disease. Nature. 2018;559(7715):S13\u20135. https:\/\/doi.org\/10.1038\/d41586-018-05722-9","journal-title":"Nature"},{"issue":"7618","key":"3732_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussi\u00e8re T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136. https:\/\/doi.org\/10.1038\/nature19323","journal-title":"Nature"},{"issue":"1","key":"3732_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13195-020-00711-5","volume":"12","author":"CM Calvin","year":"2020","unstructured":"Calvin CM, de Boer C, Raymont V, Gallacher J, Koychev I, European Prevention of Alzheimer\u2019s Dementia (EPAD) Consortium. Prediction of Alzheimer\u2019s disease biomarker status defined by the \u2018ATN framework\u2019 among cognitively healthy individuals: results from the EPAD longitudinal cohort study. Alzheimers Res Ther. 2020;12(1):143. https:\/\/doi.org\/10.1186\/s13195-020-00711-5","journal-title":"Alzheimers Res Ther"},{"key":"3732_CR14","doi-asserted-by":"publisher","unstructured":"Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv preprint 2013. https:\/\/doi.org\/10.48550\/arXiv.1303.3997","DOI":"10.48550\/arXiv.1303.3997"},{"key":"3732_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01767-y","author":"Y Hao","year":"2023","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A. Dictionary learning for integrative multimodal and scalable single-cell analysis. Nat Biotechnol. 2023. https:\/\/doi.org\/10.1038\/s41587-023-01767-y","journal-title":"Nat Biotechnol"},{"key":"3732_CR16","doi-asserted-by":"publisher","unstructured":"Becht E, McInnes L, Healy J, Dutertre CA, Kwok IWH, Ng LG et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. 2019;37:38\u201344. https:\/\/doi.org\/10.1038\/nbt.4314","DOI":"10.1038\/nbt.4314"},{"issue":"10","key":"3732_CR17","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA. Generation of cerebral organoids from human pluripotent stem cells. Nat Protoc. 2014;9(10):2329\u201340. https:\/\/doi.org\/10.1038\/nprot.2014.158","journal-title":"Nat Protoc"},{"issue":"7","key":"3732_CR18","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","volume":"21","author":"J Park","year":"2018","unstructured":"Park J, Wetzel I, Marriott I, Dreau D, D\u2019Avanzo C, Kim DY, et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer\u2019s disease. Nat Neurosci. 2018;21(7):941\u201351. https:\/\/doi.org\/10.1038\/s41593-018-0175-4","journal-title":"Nat Neurosci"},{"issue":"7467","key":"3732_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster MA, Renner M, Martin CA, Wenzel D, Bicknell LS, Hurles ME, et al. Cerebral organoids model human brain development and microcephaly. Nature. 2013;501(7467):373\u20139. https:\/\/doi.org\/10.1038\/nature12517","journal-title":"Nature"},{"issue":"3","key":"3732_CR20","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/s0025-7125(02)00002-0","volume":"86","author":"JQ Trojanowski","year":"2002","unstructured":"Trojanowski JQ, Lee VM. The role of tau in Alzheimer\u2019s disease. Med Clin North Am. 2002;86(3):615\u201327. https:\/\/doi.org\/10.1016\/s0025-7125(02)00002-0","journal-title":"Med Clin North Am"},{"issue":"6","key":"3732_CR21","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1046\/j.1471-4159.1998","volume":"71","author":"DP Hanger","year":"1998","unstructured":"Hanger DP, Betts JC, Loviny TL, Blackstock WP, Anderton BH. New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer\u2019s disease brain using nanoelectrospray mass spectrometry. J Neurochem. 1998;71(6):2465\u201376. https:\/\/doi.org\/10.1046\/j.1471-4159.1998","journal-title":"J Neurochem"},{"issue":"17","key":"3732_CR22","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.15252\/embj.201797397","volume":"36","author":"H Sasaguri","year":"2017","unstructured":"Sasaguri H, Nilsson P, Hashimoto S, Nagata K, Saito T, De Strooper B, et al. APP mouse models for Alzheimer\u2019s disease preclinical studies. EMBO J. 2017;36(17):2473\u201387. https:\/\/doi.org\/10.15252\/embj.201797397","journal-title":"EMBO J"},{"issue":"40","key":"3732_CR23","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26(40):10129\u201340. https:\/\/doi.org\/10.1523\/JNEUROSCI.1202-06","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"3732_CR24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1471-4159.2011.07476.x","volume":"120","author":"AK Ghosh","year":"2012","unstructured":"Ghosh AK, Brindisi M, Tang J. Developing beta-secretase inhibitors for treatment of Alzheimer\u2019s disease. J Neurochem. 2012;120(Suppl 1):71\u201383. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07476.x","journal-title":"J Neurochem"},{"issue":"5","key":"3732_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.stem.2013.04.008","volume":"12","author":"AM Maroof","year":"2013","unstructured":"Maroof AM, Keros S, Tyson JA, Ying SW, Ganat YM, Merkle FT, et al. Directed differentiation and functional maturation of cortical interneurons from human embryonic stem cells. Cell Stem Cell. 2013;12(5):559\u201372. https:\/\/doi.org\/10.1016\/j.stem.2013.04.008","journal-title":"Cell Stem Cell"},{"issue":"8","key":"3732_CR26","doi-asserted-by":"publisher","first-page":"e0134907","DOI":"10.1371\/journal.pone.0134907","volume":"10","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Kim KY, Gelernter J, Park IH, Zhang H. Ethanol upregulates NMDA receptor subunit gene expression in human embryonic stem cell-derived cortical neurons. PLoS ONE. 2015;10(8):e0134907. https:\/\/doi.org\/10.1371\/journal.pone.0134907","journal-title":"PLoS ONE"},{"issue":"4","key":"3732_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.stem.2016.12.007","volume":"20","author":"M Bershteyn","year":"2017","unstructured":"Bershteyn M, Nowakowski TJ, Pollen AA, Di Lullo E, Nene A, Wynshaw-Boris A, et al. Human iPSC-Derived cerebral organoids Model Cellular features of Lissencephaly and reveal prolonged mitosis of outer Radial Glia. Cell Stem Cell. 2017;20(4):435\u201349. https:\/\/doi.org\/10.1016\/j.stem.2016.12.007","journal-title":"Cell Stem Cell"},{"issue":"2","key":"3732_CR28","doi-asserted-by":"publisher","first-page":"375390","DOI":"10.1016\/j.cell.2015.06.034","volume":"162","author":"J Mariani","year":"2015","unstructured":"Mariani J, Coppola G, Zhang P, Abyzov A, Provini L, Tomasini L, et al. FOXG1-Dependent dysregulation of GABA\/Glutamate neuron differentiation in Autism Spectrum disorders. Cell. 2015;162(2):375390. https:\/\/doi.org\/10.1016\/j.cell.2015.06.034","journal-title":"Cell"},{"issue":"4","key":"3732_CR29","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/mp.2017.86","volume":"23","author":"N Mellios","year":"2018","unstructured":"Mellios N, Feldman DA, Sheridan SD, Ip JPK, Kwok S, Amoah SK, et al. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling. Mol Psychiatry. 2018;23(4):1051\u201365. https:\/\/doi.org\/10.1038\/mp.2017.86","journal-title":"Mol Psychiatry"},{"issue":"9","key":"3732_CR30","doi-asserted-by":"publisher","first-page":"e0161969","DOI":"10.1371\/journal.pone.0161969","volume":"11","author":"WK Raja","year":"2016","unstructured":"Raja WK, Mungenast AE, Lin YT, Ko T, Abdurrob F, Seo J, et al. Self-Organizing 3D human neural tissue derived from Induced Pluripotent stem cells recapitulate Alzheimer\u2019s Disease Phenotypes. PLoS ONE. 2016;11(9):e0161969.","journal-title":"PLoS ONE"},{"issue":"4","key":"3732_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1371\/journal.pone.0161969","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362. https:\/\/doi.org\/10.1371\/journal.pone.0161969","journal-title":"Alzheimers Dement"},{"issue":"16","key":"3732_CR32","doi-asserted-by":"publisher","first-page":"10825","DOI":"10.1074\/jbc.M512786200","volume":"281","author":"D Cripps","year":"2006","unstructured":"Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, Yang AJ. Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. J Biol Chem. 2006;281(16):10825\u201338. https:\/\/doi.org\/10.1074\/jbc.M512786200","journal-title":"J Biol Chem"},{"issue":"24","key":"3732_CR33","doi-asserted-by":"publisher","first-page":"20522","DOI":"10.1074\/jbc.M111.323279","volume":"287","author":"I Santa-Maria","year":"2012","unstructured":"Santa-Maria I, Varghese M, Ksiezak-Reding H, Dzhun A, Wang J, Pasinetti GM. Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of tau protein in aggresomes. J Biol Chem. 2012;287(24):20522\u201333. https:\/\/doi.org\/10.1074\/jbc.M111.323279","journal-title":"J Biol Chem"},{"issue":"2","key":"3732_CR34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/35040009","volume":"1","author":"MP Mattson","year":"2000","unstructured":"Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1(2):120\u20139. https:\/\/doi.org\/10.1038\/35040009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"3732_CR35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s42242-021-00150-7","volume":"4","author":"Z Heydari","year":"2021","unstructured":"Heydari Z, Moeinvaziri F, Agarwal T, Pooyan P, Shpichka A, Maiti TK, et al. Organoids: a novel modality in disease modeling. Biodes Manuf. 2021;4(4):689\u2013716. https:\/\/doi.org\/10.1007\/s42242-021-00150-7","journal-title":"Biodes Manuf"},{"issue":"5","key":"3732_CR36","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s42242-021-00150-7","volume":"23","author":"D Dutta","year":"2017","unstructured":"Dutta D, Heo I, Clevers H. Disease modeling in stem cell-derived 3D Organoid systems. Trends Mol Med. 2017;23(5):393\u2013410. https:\/\/doi.org\/10.1007\/s42242-021-00150-7","journal-title":"Trends Mol Med"},{"issue":"7","key":"3732_CR37","doi-asserted-by":"publisher","first-page":"dmm039347","DOI":"10.1242\/dmm.039347","volume":"12","author":"MA Lancaster","year":"2019","unstructured":"Lancaster MA, Huch M. Disease modelling in human organoids. Dis Model Mech. 2019;12(7):dmm039347. https:\/\/doi.org\/10.1242\/dmm.039347","journal-title":"Dis Model Mech"},{"key":"3732_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-med-042915-103753","volume":"68","author":"WV Graham","year":"2017","unstructured":"Graham WV, Bonito-Oliva A, Sakmar TP. Update on Alzheimer\u2019s Disease Therapy and Prevention Strategies. Annu Rev Med. 2017;68:413\u201330. https:\/\/doi.org\/10.1146\/annurev-med-042915-103753","journal-title":"Annu Rev Med"},{"issue":"1","key":"3732_CR39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13195-021-00927-z","volume":"13","author":"P van Bokhoven","year":"2021","unstructured":"van Bokhoven P, de Wilde A, Vermunt L, Leferink PS, Heetveld S, Cummings J, et al. The Alzheimer\u2019s disease drug development landscape. Alzheimers Res Ther. 2021;13(1):186. https:\/\/doi.org\/10.1186\/s13195-021-00927-z","journal-title":"Alzheimers Res Ther"},{"key":"3732_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"RJ O\u2019Brien","year":"2011","unstructured":"O\u2019Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci. 2011;34:185\u2013204. https:\/\/doi.org\/10.1146\/annurev-neuro-061010-113613","journal-title":"Annu Rev Neurosci"},{"issue":"2","key":"3732_CR41","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","volume":"81","author":"DJ Selkoe","year":"2001","unstructured":"Selkoe DJ. Alzheimer\u2019s disease: genes, proteins, and therapy. Physiol Rev. 2001;81(2):741\u201366. https:\/\/doi.org\/10.1152\/physrev.2001.81.2.741","journal-title":"Physiol Rev"},{"issue":"1","key":"3732_CR42","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/med.21622","volume":"40","author":"NM Moussa-Pacha","year":"2020","unstructured":"Moussa-Pacha NM, Abdin SM, Omar HA, Alniss H, Al-Tel TH. BACE1 inhibitors: current status and future directions in treating Alzheimer\u2019s disease. Med Res Rev. 2020;40(1):339\u201384. https:\/\/doi.org\/10.1002\/med.21622","journal-title":"Med Res Rev"},{"issue":"4","key":"3732_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","volume":"54","author":"JY Hur","year":"2022","unstructured":"Hur JY. \u03b3-Secretase in Alzheimer\u2019s disease. Exp Mol Med. 2022;54(4):433\u201346. https:\/\/doi.org\/10.1038\/s12276-022-00754-8","journal-title":"Exp Mol Med"},{"issue":"1","key":"3732_CR44","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41467-020-20440-5","volume":"12","author":"JC Park","year":"2021","unstructured":"Park JC, Jang SY, Lee D, Lee J, Kang U, Chang H, et al. A logical network-based drug-screening platform for Alzheimer\u2019s disease representing pathological features of human brain organoids. Nat Commun. 2021;12(1):280. https:\/\/doi.org\/10.1038\/s41467-020-20440-5","journal-title":"Nat Commun"},{"issue":"11","key":"3732_CR45","doi-asserted-by":"publisher","first-page":"113310","DOI":"10.1016\/j.celrep.2023.113310","volume":"42","author":"T Vanova","year":"2023","unstructured":"Vanova T, Sedmik J, Raska J, Cerna KA, Taus P, Pospisilova V, et al. Cerebral organoids derived from patients with Alzheimer\u2019s disease with PSEN1\/2 mutations have defective tissue patterning and altered development. Cell Rep. 2023;42(11):113310. https:\/\/doi.org\/10.1016\/j.celrep.2023.113310","journal-title":"Cell Rep"},{"key":"3732_CR46","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neulet.2016.12.060","volume":"639","author":"E Armijo","year":"2017","unstructured":"Armijo E, Gonzalez C, Shahnawaz M, Flores A, Davis B, Soto C. Increased susceptibility to Abeta toxicity in neuronal cultures derived from familial Alzheimer\u2019s disease (PSEN1-A246E) induced pluripotent stem cells. Neurosci Lett. 2017;639:74\u201381. https:\/\/doi.org\/10.1016\/j.neulet.2016.12.060","journal-title":"Neurosci Lett"},{"issue":"7384","key":"3732_CR47","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature10821","volume":"482","author":"MA Israel","year":"2012","unstructured":"Israel MA, Yuan SH, Bardy C, Reyna SM, Mu Y, Herrera C, et al. Probing sporadic and familial Alzheimer\u2019s disease using induced pluripotent stem cells. Nature. 2012;482(7384):216\u201320. https:\/\/doi.org\/10.1038\/nature10821","journal-title":"Nature"},{"issue":"4","key":"3732_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.stem.2013.01.009","volume":"12","author":"T Kondo","year":"2013","unstructured":"Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, et al. Modeling Alzheimer\u2019s disease with iPSCs reveals stress phenotypes associated with intracellular abeta and differential drug responsiveness. Cell Stem Cell. 2013;12(4):487\u201396. https:\/\/doi.org\/10.1016\/j.stem.2013.01.009","journal-title":"Cell Stem Cell"},{"issue":"24","key":"3732_CR49","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1089\/scd.2013.0511","volume":"23","author":"V Mahairaki","year":"2014","unstructured":"Mahairaki V, Ryu J, Peters A, Chang Q, Li T, Park TS, et al. Induced pluripotent stem cells from familial Alzheimer\u2019s disease patients differentiate into mature neurons with amyloidogenic properties. Stem Cells Dev. 2014;23(24):2996\u20133010. https:\/\/doi.org\/10.1089\/scd.2013.0511","journal-title":"Stem Cells Dev"},{"issue":"5","key":"3732_CR50","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang C, Najm R, Xu Q, Jeong DE, Walker D, Balestra ME, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24(5):647\u201357. https:\/\/doi.org\/10.1038\/s41591-018-0004-z","journal-title":"Nat Med"},{"issue":"3","key":"3732_CR51","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.stemcr.2018.01.031","volume":"10","author":"JE Young","year":"2018","unstructured":"Young JE, Fong LK, Frankowski H, Petsko GA, Small SA, Goldstein LSB. Stabilizing the Retromer Complex in a human stem cell model of Alzheimer\u2019s Disease reduces TAU phosphorylation independently of amyloid precursor protein. Stem Cell Rep. 2018;10(3):1046\u201358. https:\/\/doi.org\/10.1016\/j.stemcr.2018.01.031","journal-title":"Stem Cell Rep"},{"issue":"4","key":"3732_CR52","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1248\/bpb.b17-00364","volume":"41","author":"J Kimura","year":"2018","unstructured":"Kimura J, Shimizu K, Kajima K, Yokosuka A, Mimaki Y, Oku N, et al. Nobiletin reduces intracellular and extracellular beta-amyloid in iPS Cell-Derived Alzheimer\u2019s disease model neurons. Biol Pharm Bull. 2018;41(4):451\u20137. https:\/\/doi.org\/10.1248\/bpb.b17-00364","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"3732_CR53","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.celrep.2017.10.109","volume":"21","author":"T Kondo","year":"2017","unstructured":"Kondo T, Imamura K, Funayama M, Tsukita K, Miyake M, Ohta A, et al. iPSC-Based compound screening and in Vitro trials identify a synergistic anti-amyloid beta combination for Alzheimer\u2019s Disease. Cell Rep. 2017;21(8):2304\u201312. https:\/\/doi.org\/10.1016\/j.celrep.2017.10.109","journal-title":"Cell Rep"},{"issue":"3","key":"3732_CR54","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","volume":"24","author":"R van der Kant","year":"2019","unstructured":"van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y, et al. Cholesterol metabolism is a Druggable Axis that independently regulates tau and amyloid-beta in iPSC-Derived Alzheimer\u2019s disease neurons. Cell Stem Cell. 2019;24(3):363\u201375. https:\/\/doi.org\/10.1016\/j.stem.2018.12.013","journal-title":"Cell Stem Cell"},{"issue":"32","key":"3732_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. 2019;14(32):1\u201318. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"issue":"11","key":"3732_CR56","doi-asserted-by":"publisher","first-page":"e80373","DOI":"10.7554\/eLife.80373","volume":"30","author":"B Cakir","year":"2022","unstructured":"Cakir B, Park IH. Getting the right cells. Elife. 2022;30(11):e80373. https:\/\/doi.org\/10.7554\/eLife.80373","journal-title":"Elife"},{"issue":"3","key":"3732_CR57","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41593-023-01276-w","volume":"26","author":"BG Perez-Nievas","year":"2023","unstructured":"Perez-Nievas BG. Brain organoids fill the gap. Nat Neurosci. 2023;26(3):365. https:\/\/doi.org\/10.1038\/s41593-023-01276-w","journal-title":"Nat Neurosci"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03732-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03732-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03732-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T11:20:10Z","timestamp":1713957610000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03732-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3732"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03732-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"8 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments involving human embryonic stem cells (hESCs) were approved by the Public Institutional Review Board (Title of approved project, Brain organoid research using human embryonic stem cells; Approval no., P01-201910-41-001; Date of approval, 2019-07-17) designated by the Ministry of Health and Welfare, South Korea. All experiments involving patient-derived human induced pluripotent stem cells (hiPSCs) were approved by the institutional review board of Pusan National University Yangsan Hospital (IRB no., 04-2017-015).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have declared that no competing interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"118"}}